Clinical trial
Effect of Celecoxib on Markers of Vascular Inflammation
NCT00471341 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00471341 |
|---|---|
| Title | Effect of Celecoxib on Markers of Vascular Inflammation |
| Official title | A Pilot Study to Determine the Effect of Celecoxib on Markers of Inflammation in Patients With Hypertension and Coronary Artery Disease |
| Lead sponsor | University of Florida, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension and Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Celecoxib, placebo |
| Enrollment | 75 |
| Start date | Jul 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | May 9, 2007 |
| Last update posted | Sep 19, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: